AIM ImmunoTech CEO to Participate in Virtual Panel Presentation at the 23rd Annual BioFlorida Conference on October 29th
October 22 2020 - 7:30AM
AIM ImmunoTech Inc. (NYSE American: AIM) today announced that
Thomas K. Equels, Chief Executive Officer of AIM ImmunoTech, is
scheduled to participate in a virtual panel titled, “COVID-19:
Progress on Treatments & Prevention” on Thursday, October 29,
at 10:05 A.M. Eastern Time at the 23rd Annual BioFlorida
Conference. The presentation will be webcast live on the conference
event platform, which can be accessed here.
The BioFlorida Conference 2020 will feature
global experts in keynote and breakout sessions addressing the
latest trends in BioPharma, MedTech, HealthIT and COVID-19.
Informative programs will cover current science advancements,
business and public policy, as well as showcase Florida’s
achievements and innovation.
About AIM ImmunoTech Inc.AIM
ImmunoTech Inc. is an immuno-pharma company focused on the research
and development of therapeutics to treat multiple types of cancers,
immune disorders and viral diseases, including COVID-19, the
disease caused by the SARS-CoV-2 virus. For more information on AIM
ImmunoTech, please visit www.aimimmuno.com.
Contacts:
Crescendo Communications, LLCPhone:
212-671-1021Email: aim@crescendo-ir.com
AIM ImmunoTech IncPhone:
800-778-4042Email: IR@aimimmuno.com
AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Mar 2024 to Apr 2024
AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Apr 2023 to Apr 2024